McKesson Corp (N:MCK)

Mar 27, 2024 04:10 pm ET
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Feb 20, 2024 08:31 am ET
Thinking about trading options or stock in NVIDIA, Arm Holdings, Cisco Systems, McKesson, or Roku?
NEW YORK, Feb. 20, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, ARM, CSCO, MCK, and ROKU.
Feb 07, 2024 04:10 pm ET
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Feb 01, 2024 08:00 am ET
McKesson Corporation Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on April 1, 2024, to stockholders of record on March 1, 2024.
Jan 09, 2024 08:00 am ET
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET). Executive leadership will provide a company overview followed by a fireside chat.
Dec 27, 2023 04:10 pm ET
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Nov 01, 2023 04:10 pm ET
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Oct 26, 2023 08:00 am ET
McKesson Corporation Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on January 2, 2024, to stockholders of record on December 1, 2023.
Oct 02, 2023 08:00 am ET
Gentherm Announces Dr. Ken Washington as New Independent Director
Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken...
Sep 27, 2023 04:10 pm ET
McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Aug 02, 2023 04:10 pm ET
McKesson Corporation Reports Fiscal 2024 First Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Jul 24, 2023 08:00 am ET
McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share
The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 21, 2023 a regular dividend of $0.62 per share of common stock, a 15% increase from $0.54 per share in the prior quarter. The dividend will be payable on October 2, 2023, to stockholders of record on September 1, 2023.
Jun 28, 2023 04:10 pm ET
 McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its first-quarter fiscal 2024 financial results after market close on Wednesday, August 2, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Jun 13, 2023 06:20 pm ET
McKesson Corporation Announces the Expiration and Results of Tender Offer for Any and All 3.796% Notes Due 2024
McKesson Corporation (NYSE: MCK) (the “Company”) today announced that its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”) expired at 5:00 p.m., New York City time, on June 13, 2023 (the “Expiration Time”). As of the Expiration Time, $270,994,000, or 29.52%, of the $918,070,000 aggregate principal amount outstanding of the 2024 Notes had been validly tendered and not validly withdrawn (not including any amount of 2024 Notes submitted pursuant to guaranteed delivery procedures set forth in the Offer to P
Jun 13, 2023 04:05 pm ET
McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024
McKesson Corporation (NYSE:MCK) (the “Company”) today announced the pricing terms of its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”). The Tender Offer is being made pursuant to the terms and subject to the conditions set forth in the Offer to Purchase, dated as of June 7, 2023 (the “Offer to Purchase”) and the related notice of guaranteed delivery (together with the Offer to Purchase, the “Offer Documents”).
Jun 07, 2023 09:00 am ET
McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024
McKesson Corporation (NYSE:MCK) (the “Company”) today announced that it has commenced an offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 3.796% Notes due 2024 (the “2024 Notes”). The Tender Offer is being made pursuant to the terms and subject to the conditions set forth in the Offer to Purchase, dated as of June 7, 2023 (the “Offer to Purchase”) and the related notice of guaranteed delivery (together with the Offer to Purchase, the “Offer Documents”).
May 08, 2023 04:10 pm ET
McKesson Corporation Reports Fiscal 2023 Fourth-Quarter and Full-Year Results and Raises Long-Term Segment Growth Targets
McKesson Corporation (NYSE: MCK) has released its fiscal 2023 fourth-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Apr 27, 2023 08:00 am ET
McKesson Corporation Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on July 3, 2023, to stockholders of record on June 1, 2023.
Mar 27, 2023 04:10 pm ET
McKesson Corporation Announces Fourth-quarter Fiscal 2023 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Feb 01, 2023 04:10 pm ET
McKesson Corporation Reports Fiscal 2023 Third-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2023 third-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Jan 26, 2023 08:00 am ET
McKesson Corporation Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on April 3, 2023, to stockholders of record on March 1, 2023.
Dec 28, 2022 04:10 pm ET
McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Nov 01, 2022 04:10 pm ET
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2023 second-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Oct 27, 2022 08:00 am ET
McKesson Corporation Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on January 3, 2023, to stockholders of record on December 1, 2022.
Sep 29, 2022 04:10 pm ET
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.
Sep 19, 2022 08:36 am ET
McKesson Signs Agreement to Acquire Rx Savings Solutions
 Acquisition aligns with McKesson's strategic growth focus by connecting biopharma and payer services to patients
Sep 19, 2022 08:30 am ET
McKesson Signs Agreement to Acquire Rx Savings Solutions
McKesson Corporation (NYSE:MCK) today announced that it has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients.
Sep 13, 2022 04:05 pm ET
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
McKesson Corporation (NYSE:MCK) today announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer (CHRO). Ms. Smith will succeed Tracy L. Faber, McKesson’s current CHRO, who will be retiring after an accomplished 11-year tenure with McKesson. These changes are expected to be effective December 1, 2022.
Aug 09, 2022 10:59 am ET
Thinking about trading options or stock in Micron Technology, Constellation Brands, Novavax, McKesson Corp, or Cigna?
NEW YORK, Aug. 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MU, STZ, NVAX, MCK, and CI.
Aug 03, 2022 04:10 pm ET
McKesson Corporation Reports Fiscal 2023 First-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2023 first-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Jul 25, 2022 08:00 am ET
McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share
The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record on September 1, 2022.
Jul 11, 2022 11:25 am ET
Thinking about trading options or stock in Alibaba, Novavax, Wynn Resorts, McKesson, or Walmart?
NEW YORK, July 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, NVAX, WYNN, MCK, and WMT.
Jun 29, 2022 04:10 pm ET
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Jun 23, 2022 08:30 am ET
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (“SCRI”). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced invest
Jun 23, 2022 08:30 am ET
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investig
May 05, 2022 04:10 pm ET
McKesson Reports Fiscal 2022 Fourth-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2022 fourth-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
May 03, 2022 07:35 am ET
Distributors Agree to Opioid Settlement With Washington State
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington’s allocation under the previously announced comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities, as well as certain attorneys’ fees and costs.
Apr 28, 2022 08:00 am ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on July 1, 2022, to stockholders of record on June 1, 2022.
Apr 11, 2022 09:31 am ET
Thinking about trading options or stock in Apple, Mosaic, Kroger, Dollar General, or McKesson?
NEW YORK, April 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, MOS, KR, DG, and MCK.
Apr 07, 2022 08:00 am ET
McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
McKesson Corporation (NYSE: MCK) today announced that it has closed the transaction announced in November 2021 to sell its UK businesses to AURELIUS. This is another important step in advancing McKesson’s commitment to streamline the business and fully exit the European region.
Apr 01, 2022 08:00 am ET
McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022. With the election of Dunbar, McKesson’s board of directors increases from 11 to 12 members, 11 of whom are independent.
Feb 25, 2022 06:45 am ET
Distributors Approve Opioid Settlement Agreement
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that each company has independently determined that there is sufficient participation by states and litigating political subdivisions to proceed with a comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities.
Feb 02, 2022 04:05 pm ET
McKesson Reports Fiscal 2022 Third-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2022 third-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Jan 27, 2022 08:10 am ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on April 1, 2022, to stockholders of record on March 1, 2022.
Jan 18, 2022 05:10 pm ET
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022. McKesson expects that the board will appoint Hinton to the Compliance Committee and Governance Committee and Wilson-Thompson to the Compensation Committee and Governance Committee.
Dec 29, 2021 08:10 am ET
McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference
McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2022 financial results after market close on Wednesday, February 2, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Dec 20, 2021 06:00 am ET
McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH
McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH (“Quadrifolia”). The transaction includes the sale of McKesson Austria’s Herba Chemosan Apotheker-AG, together with Sanova Pharma GesmbH. The transaction is expected to close in fiscal 2022, subject to customary closing conditions, including receipt of required regulatory approvals.
Dec 08, 2021 08:10 am ET
McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets
McKesson Corporation (NYSE: MCK) today will host an Investor Day beginning at 1:00 p.m. ET, where executive leadership will provide an overview of the company’s progress towards its goal of delivering sustainable growth and details around the company’s long-term financial outlook.
Dec 01, 2021 08:10 am ET
McKesson to Host Investor Day on December 8, 2021
McKesson Corporation (NYSE: MCK) will host an Investor Day on Wednesday, December 8, 2021 from 1:00 PM to 4:00 PM ET in New York City. The meeting will feature presentations by McKesson’s leadership team and a live Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an overview of the company’s progress towards its goal of delivering sustainable growth and details around the company’s long-term financial outlook.
Nov 01, 2021 04:10 pm ET
McKesson Reports Fiscal 2022 Second-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2022 second-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Nov 01, 2021 07:08 am ET
McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS
McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its UK businesses to AURELIUS, a pan-European asset management group with offices in Munich, London, Stockholm, Madrid, Amsterdam, Milan and Luxembourg. The transaction includes the sale of McKesson UK businesses LloydsPharmacy, LloydsDirect (previously Echo by LloydsPharmacy), AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, LloydsPharmacy Online Doctor, MASTA and John Bell & Croyden. The transaction is expected to close in fiscal 2022, subject to customary closing conditions, including receip
Oct 28, 2021 08:10 am ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on January 3, 2022, to stockholders of record on December 1, 2021.
Sep 28, 2021 01:03 pm ET
Distributors Announce Settlement With Cherokee Nation
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Cherokee Nation to pay approximately $75 million over 6.5 years to resolve opioid-related claims. This settlement was negotiated in connection with ongoing negotiations toward a broad resolution of opioid-related claims brought by Native American tribes that, as previously disclosed by the companies, are not covered by the ongoing settlement process involving state and local governmental entities. The companies view today’s settlement as an important
Sep 27, 2021 04:10 pm ET
McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021
McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2022 financial results after market close on Monday, November 1, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Sep 07, 2021 08:23 am ET
Mckesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director
McKesson Corporation (NYSE:MCK) announced today that the McKesson board of directors has elected Dr. Richard H. Carmona as an independent director and member of the board’s Compensation and Compliance Committees, effective Sept. 6, 2021.
Aug 16, 2021 04:10 pm ET
McKesson to Host Investor Day on December 8, 2021
McKesson Corporation (NYSE:MCK) today announced that the Company will host an Investor Day on December 8, 2021 in New York City.
Aug 04, 2021 04:05 pm ET
McKesson Reports Fiscal 2022 First-Quarter Results
McKesson Corporation (NYSE: MCK) has released its fiscal 2022 first-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Jul 26, 2021 08:00 am ET
McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share
The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 23, 2021 a regular dividend of $0.47 per share of common stock, a 12% increase from $0.42 per share in the prior quarter. The dividend will be payable on October 1, 2021, to stockholders of record on September 1, 2021.
Jul 22, 2021 04:45 pm ET
McKesson Corporation Announces Pricing and Upsizing of Tender Offer
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to $500,000,000 aggregate principal amount (the “Offer”) of its outstanding 6.00% Notes due 2041 (the “6.00% Notes”), 4.883% Notes due 2044 (the “4.883% Notes”), 7.65% Debentures due 2027 (the “7.65% Debentures”), 4.750% Notes due 2029 (the “4.750% Notes”), 3.950% Notes due 2028 (the “3.950% Notes”), 2.85% Notes due 2023 (the “2.85% Notes”) and 3.796% Notes due 2024 (the “3.796% Note
Jul 22, 2021 08:00 am ET
McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to $500,000,000 (subject to increase, the “Tender Cap”) aggregate principal amount (the “Offer”) of its outstanding 6.00% Notes due 2041 (the “6.00% Notes”), 4.883% Notes due 2044 (the “4.883% Notes”), 7.65% Debentures due 2027 (the “7.65% Debentures”), 4.750% Notes due 2029 (the “4.750% Notes”), 3.950% Notes due 2028 (the “3.950% Notes”), 2.85% Notes due 2023 (the “2.85% Notes”) and
Jul 21, 2021 02:15 pm ET
Distributors Announce Proposed Opioid Settlement Agreement
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities.
Jul 20, 2021 09:50 am ET
Thinking about trading options or stock in McKesson Corp, Cardinal Health, TAL Education Group, Cassava Sciences, or Moderna?
NEW YORK, July 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MCK, CAH, TAL, SAVA, and MRNA.
Jul 20, 2021 09:17 am ET
Distributors Reach Opioid Settlement Agreement With New York State
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the ongoing negotiations toward a broad resolution under the previously disclosed settlement framework intended to resolve claims brought by other states, counties and other political subdivisions. The companies view today’s settlement as an import
Jul 08, 2021 08:00 am ET
McKesson Corporation Announces Offer to Purchase up to $500 Million Aggregate Principal Amount of Debt
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the commencement of a cash tender offer to purchase up to $500,000,000 (subject to increase, the “Tender Cap”) aggregate principal amount (the “Offer”) of its outstanding 6.00% Notes due 2041 (the “6.00% Notes”), 4.883% Notes due 2044 (the “4.883% Notes”), 7.65% Debentures due 2027 (the “7.65% Debentures”), 4.750% Notes due 2029 (the “4.750% Notes”), 3.950% Notes due 2028 (the “3.950% Notes”), 2.85% Notes due 2023 (the “2.85% Notes”) and 3.796% Notes due 2024 (the “3.796% Notes” and together with the 6.00% Notes, the 4.883% Notes
Jul 07, 2021 08:00 am ET
McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group
McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its European businesses in France, Italy, Ireland, Portugal, Belgium, and Slovenia to the PHOENIX group. This transaction also includes McKesson’s German-based AG headquarters in Stuttgart, Recucare GmbH, its German wound-care business, its shared services center in Lithuania, and its 45% ownership stake in Brocacef, the company’s joint venture in the Netherlands. The transaction is expected to close in 2022, subject to customary closing conditions, including receipt of required regulatory approvals.
Jun 30, 2021 04:10 pm ET
McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021
McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2022 financial results after market close on Wednesday, August 4, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
May 06, 2021 04:05 pm ET
McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results
McKesson Corporation (NYSE:MCK) today reported results for the fourth quarter and fiscal year ended March 31, 2021.
Apr 29, 2021 04:10 pm ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on July 1, 2021, to stockholders of record on June 1, 2021.
Apr 01, 2021 04:10 pm ET
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
Feb 02, 2021 07:00 am ET
McKesson Reports Fiscal 2021 Third-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the third quarter ended December 31, 2020.
Jan 28, 2021 04:10 pm ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on April 1, 2021, to stockholders of record on March 2, 2021.
Dec 28, 2020 04:10 pm ET
McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences
McKesson Corporation (NYSE:MCK) will release its third quarter fiscal 2021 financial results before market open on Tuesday, February 2, 2021. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results.
Nov 19, 2020 04:15 pm ET
McKesson Appoints Dr. Kelvin A. Baggett to Chief Impact Officer
McKesson Corporation (NYSE:MCK) today announced that the company has appointed Dr. Kelvin A. Baggett to the newly created role of chief impact officer, effective November 30, 2020.
Nov 03, 2020 07:00 am ET
McKesson Reports Fiscal 2021 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the second quarter ended September 30, 2020.
Nov 02, 2020 03:00 am ET
Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture
Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.
Oct 29, 2020 04:10 pm ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on January 4, 2021, to stockholders of record on December 1, 2020.
Oct 19, 2020 07:00 am ET
McKesson’s Board of Directors Elects Linda Mantia as New Independent Director
McKesson Corporation (NYSE: MCK) today announced that the McKesson board of directors has elected Linda Mantia as an independent director and member of the board’s Audit and Governance Committees, effective Oct. 19, 2020. With the election of Mantia, McKesson’s board of directors increases from 11 to 12 members, 11 of whom are independent.
Oct 05, 2020 04:10 pm ET
McKesson Corporation to Announce Second Quarter Fiscal 2021 Results on November 3, 2020
McKesson Corporation (NYSE:MCK) will release its second quarter fiscal 2021 financial results before market open on Tuesday, November 3, 2020. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results.
Aug 14, 2020 01:59 pm ET
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
A global leader in the healthcare industry, McKesson Corporation (NYSE: MCK) will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed (OWS) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. Vaccines and related supplies will be delivered to point-of-care sites across the country at the U.S. government’s direction.
Aug 03, 2020 07:00 am ET
McKesson Reports Fiscal 2021 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the first quarter ended June 30, 2020.
Jul 29, 2020 04:27 pm ET
McKesson Declares Quarterly Dividend July 29, 2020
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on October 1, 2020, to stockholders of record on September 1, 2020.
Jul 06, 2020 04:10 pm ET
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020
McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2021 financial results before market open on Monday, August 3, 2020. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results.
Jul 01, 2020 04:10 pm ET
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
McKesson Corporation (NYSE:MCK) today announces changes to its reportable business structure. The Company has revised its reportable segments commencing in the second quarter of fiscal 2021.
Jun 04, 2020 04:15 pm ET
McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer
McKesson Corporation (NYSE:MCK) today announced Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team. Rodgers succeeds Bansi Nagji who stepped down from his role effective March 31, 2020.
May 20, 2020 07:00 am ET
McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
McKesson Corporation (NYSE:MCK) today reported results for the fourth quarter and fiscal year ended March 31, 2020.
Apr 29, 2020 04:10 pm ET
McKesson Declares Quarterly Dividend April 29, 2020
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on July 1, 2020, to stockholders of record on June 1, 2020.
Apr 20, 2020 04:10 pm ET
McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020
McKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020. The company will host a conference call for investors at 8:00 AM Eastern Time to review its financial results.
Mar 23, 2020 04:46 pm ET
McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.
Mar 17, 2020 04:10 pm ET
McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off
McKesson Corporation (NYSE:MCK) today announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020.
Mar 12, 2020 08:00 am ET
McKesson Announces Final Results of Exchange Offer
McKesson Corporation (NYSE:MCK) today announced the final results of its offer to its stockholders to exchange their issued and outstanding shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by McKesson as part of its split-off of its interest in Change Healthcare LLC (“Change Healthcare”) and its agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and into Change.
Mar 10, 2020 09:00 am ET
McKesson Completes Split-off of Its Interest in Change Healthcare
McKesson Corporation (NYSE:MCK) today announced the completion of the split-off of PF2 SpinCo, Inc. (“SpinCo”), which held McKesson’s interest in Change Healthcare LLC (“Change Healthcare”) and which was merged with and into Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) through a “Reverse Morris Trust” transaction. The closing of the merger followed the previously announced expiration of McKesson’s exchange offer. As a result of the merger, participating McKesson stockholders will receive one share of Change common stock in exchange for each whole share of SpinCo common stock they received i
Mar 10, 2020 08:00 am ET
McKesson Announces Preliminary Results of Exchange Offer
McKesson Corporation (NYSE:MCK) today announced that its previously announced offer to stockholders to exchange their shares of McKesson common stock on a per-share-basis for 11.4086 shares of PF2 SpinCo, Inc. (“SpinCo”) common stock expired at 11:59 p.m., New York City time, on March 9, 2020, and, based on preliminary results, the exchange offer was oversubscribed. The exchange offer to split-off SpinCo, which holds McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), is part of McKesson’s agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and i
Mar 05, 2020 05:50 pm ET
McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer
McKesson Corporation (NYSE:MCK) today announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock. The exchange offer to split-off SpinCo, which holds McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), is part of McKesson’s agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and into Change.
Feb 10, 2020 07:31 am ET
McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
McKesson Corporation (NYSE:MCK) today announced the commencement of an exchange offer for the split-off of its wholly-owned subsidiary, PF2 SpinCo, Inc. (“SpinCo”), which will hold all of McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), as part of McKesson’s previously announced agreement with Change Healthcare Inc. (Nasdaq:CHNG) (“Change”) to merge SpinCo with and into Change.
Feb 04, 2020 07:00 am ET
McKesson Reports Fiscal 2020 Third Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the third quarter ended December 31, 2019.
Jan 29, 2020 04:10 pm ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on April 1, 2020, to stockholders of record on March 2, 2020.
Jan 13, 2020 04:10 pm ET
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
McKesson Corporation (NYSE:MCK) will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco tomorrow, January 14, 2020 at 9:00 AM PT (12:00 PM ET). Brian Tyler, chief executive officer of McKesson, will provide a company overview and review topics including:
Jan 03, 2020 09:00 am ET
McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020
McKesson Corporation (NYSE:MCK) announced today that its third quarter fiscal 2020 financial results will be released before market open on Tuesday, February 4, 2020. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results.
Dec 18, 2019 08:30 am ET
McKesson Reaffirms Fiscal 2020 Guidance
McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $14.00 to $14.60 for the fiscal year ending March 31, 2020.
Dec 12, 2019 11:01 am ET
McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider
McKesson Corporation (NYSE: MCK) announced today that it has been selected by the Department of Veterans Affairs (VA), which runs the nation’s largest integrated healthcare system, to continue as the prime pharmaceutical supplier for the agency. Under the new agreement, which takes effect in Aug. 2020, McKesson will supply all of the VA's medical centers and outpatient clinics, as well as the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). The initial two-year contract includes options for up to three, two-year extensions.
Dec 12, 2019 04:00 am ET
Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture
Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today signed an agreement to create a joint venture that will combine their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA will have a 70% controlling equity interest in the joint venture and McKesson will have a 30% ownership interest.
Dec 10, 2019 04:10 pm ET
McKesson to Host Sell-Side Analyst Meeting on December 18, 2019
McKesson Corporation (NYSE: MCK) announced today it will host a sell-side analyst meeting on Wednesday, December 18, 2019 at its corporate headquarters in Irving, Texas. During the meeting, CEO Brian Tyler and CFO Britt Vitalone will provide a general business update.
Dec 09, 2019 04:10 pm ET
McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer
McKesson Corporation (NYSE:MCK) today announced that Nancy Flores will join McKesson as its new executive vice president, chief information officer (CIO) and chief technology officer (CTO) on Jan. 13, 2020, succeeding Kathy McElligott who announced her retirement earlier this year. Flores currently serves as CIO for Johnson Controls, where she is responsible for Global Business Services, which includes back office shared services, information technology, cybersecurity and analytics.
Nov 14, 2019 08:33 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Meredith Corporation, McKesson Corporation, Maxar Technologies, and ViewRay and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Meredith Corporation (NYSE: MDP), McKesson Corporation (NYSE: MCK), Maxar Technologies, Inc. (NYSE: MAXR), and ViewRay,...
Nov 08, 2019 10:59 pm ET
McKesson (MCK) Alert: Johnson Fistel Announces Shareholder Class Action Against McKesson Corporation Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?
SAN DIEGO, Nov. 8, 2019 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of McKesson Corporation (NYSE: MCK) ("McKesson" or the "Company") against certain of its officers and directors. 
Oct 30, 2019 07:00 am ET
McKesson Reports Fiscal 2020 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the second quarter ended September 30, 2019.
Oct 23, 2019 04:10 pm ET
McKesson Declares Quarterly Dividend October 23, 2019
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on January 2, 2020, to stockholders of record on December 2, 2019.
Oct 21, 2019 11:38 am ET
Distributors Reach Settlement With Ohio Counties in Opioids Case
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation. With this settlement agreed upon, the companies and the other parties will now continue the work toward a global resolution.
Sep 30, 2019 04:10 pm ET
McKesson Corporation to Announce Second Quarter Fiscal 2020 Results on October 30, 2019
McKesson Corporation (NYSE:MCK) announced today that its second quarter fiscal 2020 financial results will be released before market open on Wednesday, October 30, 2019. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results.
Jul 31, 2019 04:10 pm ET
McKesson Reports Fiscal 2020 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2019, were $55.7 billion compared to $52.6 billion a year ago, an increase of 6% on a reported basis and an increase of 7% on an FX-adjusted basis.
Jun 27, 2019 04:12 pm ET
McKesson Corporation to Announce First Quarter Fiscal 2020 Results on July 31, 2019
McKesson Corporation (NYSE:MCK) announced today that its first quarter fiscal 2020 financial results will be released on Wednesday, July 31, 2019 following the close of market. The company will host a conference call at 5:00 PM Eastern Time (2:00 PM Pacific Time) the same day to discuss the financial results. During this call, the company will also provide an update on fiscal 2020 outlook assumptions following the completion of the Change Healthcare initial public offering.
Jun 27, 2019 04:10 pm ET
McKesson Issues Statement on Change Healthcare IPO
McKesson Corporation (NYSE:MCK) offers the below statement on today’s Change Healthcare initial public offering:
Jun 17, 2019 04:10 pm ET
McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director
McKesson Corporation (NYSE:MCK) today announced that its board of directors elected Dr. Ken Washington as a new independent director, effective July 1, 2019. With the election of Dr. Washington, McKesson’s board of directors increases from nine to ten members, nine of whom are independent.
May 08, 2019 05:25 pm ET
CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results
Schedule 5, Condensed Consolidated Statements of Cash Flows is corrected to include the line “Gain from Sale of Businesses and Investments” and the corresponding amounts for the years ended March 31, 2018 and 2019. This correction does not impact net cash provided by operating activities as previously presented for either period.
May 02, 2019 12:15 pm ET
McKesson Reaches Settlement With State of West Virginia on Opioid Order Monitoring and Reporting
McKesson Corporation (NYSE:MCK) today announced that it has settled litigation with the State of West Virginia to resolve all claims regarding McKesson’s operations in the state.
Apr 26, 2019 04:31 pm ET
McKesson Appoints Tracy Faber to Top HR Role
McKesson Corporation (NYSE:MCK) today announced that Tracy Faber has been appointed executive vice president and chief human resources officer (CHRO), effective October 1, 2019. Faber will report to CEO Brian Tyler.
Apr 24, 2019 04:10 pm ET
McKesson Declares Quarterly Dividend April 24, 2019
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-nine cents per share on Common Stock. The dividend will be payable on July 1, 2019, to stockholders of record on June 3, 2019.
Apr 15, 2019 04:30 pm ET
Kirk Kaminsky to Lead McKesson’s U.S.-Based Pharmaceutical Business
McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical and Specialty Solutions (USPSS) business. Kaminsky will assume the role effective immediately, reporting to CEO Brian Tyler.
Apr 10, 2019 04:10 pm ET
McKesson Corporation to Hold Fiscal 2019 Fourth Quarter Conference Call and Participate in the Bank of America Merrill Lynch Health Care Conference
McKesson Corporation (NYSE:MCK) will release financial results for its fourth quarter ended March 31, 2019 on Wednesday, May 8, 2019, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which Brian Tyler, chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Feb 08, 2019 08:10 am ET
Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Amerco (NASDAQ:UHAL), McKesson Corporation (NYSE:MCK), Ophthotech...
Jan 31, 2019 04:10 pm ET
McKesson Reports Fiscal 2019 Third-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2018, were $56.2 billion, up 5% compared to $53.6 billion a year ago, and also up 5% on a constant currency basis. On the basis of U.S. generally accepted accounting principles (“GAAP”), third-quarter earnings per diluted share from continuing operations was $2.41, compared to earnings per diluted share of $4.32 a year ago. Prior year GAAP earnings per diluted share included a net tax benefit of approximately $1.78 per diluted share driven by th
Jan 07, 2019 04:15 pm ET
McKesson Corporation Fiscal 2019 Third Quarter Conference Call Scheduled for January 31, 2019
McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2018 on Thursday, January 31, 2019, following the market close at approximately 4:00 PM Eastern Time (1:00 PM Pacific Time). The company has scheduled a conference call for 5:00 PM Eastern Time (2:00 PM Pacific Time), during which John Hammergren, chairman and chief executive officer, Brian Tyler, president and chief operating officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jan 07, 2019 08:30 am ET
McKesson and Genpact Expand Their Relationship to Support McKesson’s Finance Operating Model Optimization
McKesson (NYSE:MCK), a leader in healthcare supply chain management solutions and healthcare information technology, and Genpact (NYSE:G), a global professional services firm focused on delivering process transformation, today announced the expansion of their relationship that will advance McKesson’s finance operating model and cost structu
Dec 26, 2018 10:00 am ET
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) & Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 26, 2018 08:40 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 24, 2018 10:26 am ET
MCK EQUITY NOTICE: Rosen Law Announces Filings of Securities Class Action Against McKesson Corporation; Important Dec. 26 Deadline - MCK
NEW YORK, Dec. 24, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of McKesson Corporation (NYSE: MCK) from October 24, 2013 through January 25, 2017, inclusive (the "Class Period") of the important December 26, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for McKesson investors under the federal securities laws.
Dec 24, 2018 08:55 am ET
WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Dec 21, 2018 05:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980....
Dec 21, 2018 12:00 pm ET
WEDNESDAY DEADLINE The Schall Law Firm Announces it is Investigating Claims Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Dec 20, 2018 03:57 pm ET
DECEMBER 26 DEADLINE: Rosen Law Firm Reminds McKesson Corporation Investors of Important Deadline in Class Action – MCK
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of McKesson Corporation (NYSE: MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class...
Dec 20, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) & Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 19, 2018 04:13 pm ET
Rite Aid and McKesson Agree to Key Terms for Pharmaceutical Purchasing and Distribution
Rite Aid Corporation (NYSE:RAD) and McKesson Corporation (NYSE:MCK) announced an agreement to key terms that will continue the companies’ pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029.
Dec 17, 2018 01:53 pm ET
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against McKesson Corporation
Law Offices of Howard G. Smith reminds investors of the December 18, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK)...
Dec 17, 2018 11:40 am ET
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 14, 2018 05:55 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980....
Dec 11, 2018 12:33 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against McKesson Corporation
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 26, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE:...
Dec 11, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 10, 2018 03:30 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 07, 2018 04:52 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Dec 07, 2018 07:50 am ET
Consolidated Research: 2018 Summary Expectations for Equifax, Celanese, McKesson, ManpowerGroup, NewMarket, and Phillips 66 — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Equifax, Inc. (NYSE:EFX), Celanese Corporation (NYSE:CE), McKesson...
Dec 05, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 04, 2018 06:05 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against McKesson Corporation
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 26, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE:
Dec 03, 2018 03:21 pm ET
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against McKesson Corporation
Law Offices of Howard G. Smith reminds investors of the December 18, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) securities between October 24, 2013 and January 25, 2017, inclus
Dec 03, 2018 02:51 pm ET
INVESTOR NOTICE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 30, 2018 07:30 pm ET
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of McKesson Corporation Investors (MCK)
Glancy Prongay & Murray LLP (“GPM”), a global investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired McKesson Corporation (“McKesson” or the “Company”) (NYSE: 
Nov 30, 2018 05:32 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Nov 30, 2018 04:15 pm ET
McKesson Announces New Global Headquarters in Las Colinas, Texas
McKesson Corporation (NYSE:MCK) today announced the relocation of its corporate headquarters from San Francisco, California to Las Colinas, Texas, effective April 1, 2019, expanding upon its presence in the Dallas area.
Nov 29, 2018 08:32 pm ET
Glancy Prongay & Murray LLP Announces Investigation on Behalf of McKesson Corporation Investors (MCK)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of McKesson Corporation(“McKesson” or the “Company”) (NYSE:
Nov 29, 2018 05:47 pm ET
MCK LOSS NOTICE: Rosen Law Firm Reminds McKesson Corporation Investors of Important Deadline in Class Action – MCK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of McKesson Corporation (NYSE:MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class Period”) of the important December 26, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for McKesson investors under the federal securities laws.
Nov 29, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Nov 28, 2018 07:58 pm ET
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of McKesson Corporation Investors (MCK)
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) securities between October 24, 2013 and January 25, 2017 inclusive (the “Class Period”). McKesson investors have until December 26,
Nov 26, 2018 04:05 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of McKesson Corporation Investors (MCK)
Law Offices of Howard G. Smith announces an investigation on behalf of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) investors concerning the Company and its officers’ possible violations of federal securities laws.
Nov 26, 2018 12:00 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 23, 2018 06:32 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Nov 19, 2018 01:59 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 16, 2018 05:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980....
Nov 16, 2018 03:49 pm ET
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the F
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Nov 15, 2018 10:38 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Nov 15, 2018 07:07 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against McKesson Corporation – MCK
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of McKesson Corporation (NYSE:MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for McKesson investors under the federal securities laws.
Nov 09, 2018 07:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Nov 08, 2018 06:15 pm ET
CURRENT SHAREHOLDERS: Zamansky LLC Investigates McKesson (MCK) for Potential Breaches of Fiduciary Duties
Zamansky LLC announces that it is investigating McKesson Corporation (NYSE:MCK) (“McKesson” or the “Company”) for potential breaches of fiduciary duties by its senior officers and board of directors. If you are a shareholder of McKesson who still holds your shares, please contact our firm for information.
Nov 02, 2018 08:07 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE:MCK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Nov 01, 2018 04:15 pm ET
John Hammergren Announces Retirement; Brian Tyler to Become McKesson’s CEO and Edward Mueller to Chair Board
McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided to retire, effective March 31, 2019. McKesson’s Board of Directors has unanimously selected Brian Tyler, 51, currently president and chief operating officer (COO), to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president.
Oct 30, 2018 08:20 am ET
Research Report Identifies Deckers Outdoor, Navient, Phillips 66, BioMarin Pharmaceutical, McKesson, and Equity Residential with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Deckers Outdoor Corporation (NYSE:DECK), Navient Corporation...
Oct 29, 2018 07:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claim On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...
Oct 29, 2018 02:57 pm ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline: December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Oct 26, 2018 10:35 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of McKesson Corporation (MCK)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK). Such investors are encouraged to obtain additional information...
Oct 26, 2018 08:05 am ET
Shareholder Alert - Bleichmar Fonti & Auld LLP Files Securities Class Action Lawsuit Against McKesson Corporation
Bleichmar Fonti & Auld LLP (“BFA”) announces that it has filed a class action lawsuit on behalf of a class (the “Class”) consisting of persons and entities that acquired McKesson Corporation (“McKesson” or the “Company”) (NYSE:MCK) common stock...
Oct 25, 2018 07:00 am ET
McKesson Reports Fiscal 2019 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2018, were $53.1 billion, up 2% compared to $52.1 billion a year ago, and also up 2% on a constant currency basis. On the basis of U.S. generally accepted accounting principles (“GAAP”), second-quarter earnings per diluted share from continuing operations was $2.51, compared to earnings per diluted share of $0.01 a year ago. GAAP earnings per diluted share included a pre-tax benefit of $90 million, or $0.33 per diluted share, related to a
Oct 04, 2018 04:10 pm ET
McKesson Corporation Fiscal 2019 Second Quarter Conference Call Scheduled for October 25, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its second fiscal quarter ended September 30, 2018 on Thursday, October 25, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Sep 13, 2018 04:10 pm ET
McKesson Board of Directors Elects Dominic Caruso as New Independent Director
McKesson Corporation (NYSE:MCK) today announced that its Board of Directors has elected Dominic Caruso as a new independent director, effective September 12, 2018. With the election of Dominic Caruso, McKesson’s Board of Directors increases from eight to nine members, eight of whom are independent.
Aug 23, 2018 04:10 pm ET
McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference
McKesson Corporation (NYSE:MCK) announced that Britt Vitalone, the company’s executive vice president and chief financial officer, will present at the Morgan Stanley Global Healthcare Conference in New York at 10:30 a.m. ET on Friday, September 14, 2018. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Jul 31, 2018 09:00 am ET
McKesson Appoints Brian Tyler as President and Chief Operating Officer
McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.
Jul 26, 2018 07:00 am ET
McKesson Reports Fiscal 2019 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2018, were $52.6 billion, up 3% compared to $51.1 billion a year ago. On a constant currency basis, revenues increased 2% over the prior year. On the basis of U.S. generally accepted accounting principles (“GAAP”), first-quarter loss per diluted share from continuing operations was $(0.69), compared to earnings per diluted share of $1.44 a year ago. GAAP loss per diluted share included a pre-tax and after-tax non-cash goodwill impairment charge of $
Jul 25, 2018 03:09 pm ET
McKesson Announces Preliminary Voting Results from 2018 Annual Meeting of Stockholders
McKesson Corporation (NYSE:MCK) today announced preliminary voting results from its Annual Meeting of Stockholders, held earlier today in Irving, Texas. All directors were re-elected, the non-binding advisory vote on executive compensation was approved, and all Board vote recommendations were supported.
Jul 05, 2018 04:10 pm ET
McKesson Corporation Fiscal 2019 First Quarter Conference Call Scheduled for July 26, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jun 28, 2018 09:00 am ET
McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter
McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $13.00 to $13.80 for the fiscal year ending March 31, 2019, and the underlying key assumptions provided in its press release on May 24, 2018. The company also anticipates Adjusted Earnings per diluted share of approximately $2.85 to $2.95 for the first quarter of Fiscal 2019.
Jun 27, 2018 07:45 am ET
Investor Expectations to Drive Momentum within CenterPoint Energy, Univar, NOW, McKesson, Brinker International, and TAL Education Group — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CenterPoint Energy, Inc. (NYSE:CNP), Univar Inc. (NYSE:UNVR), NOW Inc....
Jun 12, 2018 09:00 am ET
Pharmapacks Raises $32.5 Million to Fund Expansion, Automation and Talent Acquisition
ISLANDIA, N.Y., June 12, 2018 /PRNewswire/ -- Pharmapacks, a leading e-commerce company with a proprietary technology platform that empowers brands to reach millions of consumers with a complete and cost-effective logistics, fulfillment, marketing and sales solution, today announced it has raised $32.5 million by selling a minority stake at an undisclosed valuation. The strategic round was led by multinational CPG company RB (LSE: RB) with additional investments from McKesson Ventures, Sealed Air (NYSE:SEE) and The Emerson Group.
Jun 01, 2018 09:10 am ET
McKesson Completes Acquisition of Medical Specialties Distributors
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of Medical Specialties Distributors.
May 29, 2018 04:10 pm ET
McKesson Corporation to Present at the Goldman Sachs 39th Annual Global Healthcare Conference and Host Investor Day
McKesson Corporation (NYSE:MCK) today announced that Britt Vitalone, executive vice president and chief financial officer, will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, CA at 2:00 p.m. PT on Wednesday, June 13, 2018.
May 24, 2018 07:00 am ET
McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2018, were $51.6 billion, up 6% compared to $48.7 billion a year ago. On a constant currency basis, revenues increased 4% over the prior year. For the fiscal year, McKesson had revenues of $208.4 billion, up 5% compared to $198.5 billion a year ago. On a constant currency basis, revenues increased 4% over the prior year.
May 11, 2018 08:25 am ET
Consolidated Research: 2018 Summary Expectations for STORE Capital, Microvision, International Game Technology, McKesson, Marinus Pharmaceuticals, and Alnylam Pharmaceuticals — Fundamental Analysis, K
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STORE Capital Corporation (NYSE:STOR), Microvision, Inc. (NASDAQ:MVIS),...
Apr 30, 2018 09:02 am ET
McKesson Board of Directors Elects Brad Lerman as New Independent Director
McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected Brad Lerman as a new independent director, effective April 24, 2018. With the election of Mr. Lerman, the size of McKesson’s Board of Directors increases from eight to nine members, eight of whom are independent.
Apr 30, 2018 09:00 am ET
McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its fourth fiscal quarter ended March 31, 2018 on Thursday, May 24, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Apr 25, 2018 04:10 pm ET
McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook
McKesson Corporation (NYSE:MCK) today announced a multi-year strategic growth initiative, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance.
Feb 22, 2018 04:10 pm ET
McKesson Corporation Announces Pricing of Tender Offer
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to $1,100,000,000 (the “Tender Cap”) combined aggregate purchase price (the “Offer”) of its outstanding 6.000% Notes due 2041 (the “6.000% Notes”), 7.650% Debentures due 2027 (the “7.650% Debentures”), 4.883% Notes due 2044 (the “4.883% Notes”), 4.750% Notes due 2021 (the “4.750% Notes”) and 7.500% Notes due 2019 (the “7.500% Notes” an
Feb 22, 2018 09:20 am ET
McKesson Corporation Announces Early Tender Results
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to $1,100,000,000 (the “Tender Cap”) combined aggregate purchase price (the “Offer”) of its outstanding 6.000% Notes due 2041 (the “6.000% Notes”), 7.650% Debentures due 2027 (the “7.650% Debentures”), 4.883% Notes due 2044 (the “4.883% Notes”), 4.750% Notes due 2021 (the “4.750% Notes”) and 7.500% Notes due 2019 (the “7.500% Notes” an
Feb 07, 2018 08:30 am ET
New Research Coverage Highlights Zions, McKesson, Sealed Air, CenterPoint Energy, Coca-Cola European Partners, and KKR & Co. — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zions Bancorporation (NASDAQ:ZION), McKesson Corporation (NYSE:MCK),...
Feb 07, 2018 02:58 am ET
McKesson Corporation Announces Offer to Purchase Up to $1,100,000,000 Combined Purchase Price of Outstanding 6.000% Notes due 2041, 7.650% Debentures due 2027, 4.883% Notes due 2044, 4.750% Notes due
SAN FRANCISCO, Feb. 7, 2018 /PRNewswire/ -- McKesson Corporation (NYSE: MCK) (the "Company") today announced the commencement of a cash tender offer to purchase up to $1,100,000,000 (subject to increase, the "Tender Cap") combined aggregate purchase price (the "Offer") of its outstanding 6.000% Notes due 2041 (the "6.000% Notes"), 7.650% Debentures due 2027 (the "7.650% Debentures"), 4.883% Notes due 2044 (the "4.883% Notes"), 4.750% Notes due 2021 (the "4.750% Notes") and 7.500% Notes due 2019 (the "7.500% Notes" and together with the 6.000% Notes, the 7.650% Debentures, the 4.883% Notes
Feb 01, 2018 07:00 am ET
McKesson Reports Fiscal 2018 Third-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2017, were $53.6 billion, up 7% compared to $50.1 billion a year ago. On the basis of U.S. generally accepted accounting principles (“GAAP”), third-quarter earnings per diluted share from continuing operations was $4.32, compared to $2.86 a year ago. Third-quarter GAAP earnings per diluted share included a net tax benefit of approximately $370 million, or $1.78, driven by the Tax Cuts and Jobs Act of 2017.
Jan 04, 2018 04:10 pm ET
McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for February 1, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2017 on Thursday, February 1, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jan 03, 2018 09:00 am ET
McKesson Completes Acquisition of RxCrossroads
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads.
Dec 19, 2017 04:10 pm ET
McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference
McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:30 a.m. PT on Tuesday, January 9, 2018. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Dec 18, 2017 09:00 am ET
McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook
McKesson Corporation (NYSE:MCK) today announced James Beer, executive vice president and chief financial officer, will be leaving the company to pursue a new opportunity. Britt Vitalone, senior vice president and chief financial officer, U.S. Pharmaceutical and McKesson Specialty Health, will be appointed executive vice president and chief financial officer of McKesson, effective January 1, 2018. Beer will assist in a transition period into early 2018. In addition, today the company reaffirmed its outlook of Adjusted Earnings of $11.80 to $12.50
Nov 17, 2017 07:35 am ET
New Research Coverage Highlights Zions, McKesson, Sealed Air, CenterPoint Energy, Coca-Cola European Partners, and KKR & Co. — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zions Bancorporation (NASDAQ:ZION), McKesson Corporation (NYSE:MCK),...
Nov 06, 2017 04:16 pm ET
McKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroads
McKesson Corporation (NYSE:MCK) today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation (NYSE:CVS).
Oct 26, 2017 07:00 am ET
McKesson Reports Fiscal 2018 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2017, were $52.1 billion, up 4% compared to $50.0 billion a year ago. On the basis of U.S. generally accepted accounting principles (“GAAP”), second-quarter earnings per diluted share from continuing operations was $0.01, compared to $1.35 a year ago. During the quarter, McKesson initiated a number of strategic and operational actions within our U.K. retail pharmacy business in response to the previously discussed U.K. government reimbursement
Oct 17, 2017 04:10 pm ET
McKesson Corporation to Present at the 26th Annual Credit Suisse Healthcare Conference
McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 26th Annual Credit Suisse Healthcare Conference in Scottsdale at 10:20 a.m. MST on Tuesday, November 7, 2017. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Oct 05, 2017 04:10 pm ET
McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017
McKesson Corporation (NYSE:MCK) will release financial results for its second fiscal quarter ended September 30, 2017 on Thursday, October 26, 2017, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and James Beer, executive vice president and chief financial officer, will review these results.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.